The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development. Richmond Pharmacology’s CEO, Jorg Taubel M.D. will be presenting three posters covering the following themes:

  • Meta-analysis of the effect of a meal on QTcF
  • Effect of Glucose Alone and in Collaboration with Moxifloxacin on Cardiac Repolaration in Male and Female Patents with Type I Diabetes
  • Effects of Progesterone and Estradiol on Subintervals over the Course of a Menstrual Cycle

Learn more about our Japanese Bridging Studies here or by using the View Publications link below.

Latest news

Richmond Pharmacology appoints Sandra Johnson as Director of Commercial Project Management

September 19, 2022
We are delighted to announce that Sandra Johnson will join Richmond Pharmacology as its new Director for Commercial Project Management
Read more

How telemonitoring can revolutionise the way we treat patients – Tom York

November 17, 2022
Richmond Pharmacology always searches for the most innovative processes to improve clinical trials and the patients’ experiences and treatments.
Read more

Events

JPW2022 (Japan Basic and Clinical Pharmacology Week 2022)

30 November – 3 December 2022
This event will be the 96th Annual Meeting of the Japanese Pharmacological Society and the 43rd Annual Meeting of the Japanese Society of Clinical Pharmacology. 
View event